Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine for hypotension in premature and full-term neonates
NL-OMON42050Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of norepinephrine in hypotension and Shock, sponsored by Radboud University Medical Center. Primary endpoints: Change in blood pressure and Change in systemic blood flow. Planned start May 2015; status: withdrawn.
02
Drugs
norepinephrine
03
Conditions
hypotensionShock
Beyond the preview
Go deeper on NL-OMON42050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42050.